Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cavitation Technologies (CVAT) Liabilities and Shareholders Equity (2016 - 2025)

Cavitation Technologies (CVAT) has disclosed Liabilities and Shareholders Equity for 15 consecutive years, with $55000.0 as the latest value for Q4 2025.

  • Quarterly Liabilities and Shareholders Equity fell 92.34% to $55000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $988000.0 through Dec 2025, down 25.04% year-over-year, with the annual reading at $297000.0 for FY2025, 19.76% up from the prior year.
  • Liabilities and Shareholders Equity hit $55000.0 in Q4 2025 for Cavitation Technologies, down from $60000.0 in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $3.0 million in Q3 2021 to a low of $55000.0 in Q4 2025.
  • Historically, Liabilities and Shareholders Equity has averaged $1.1 million across 5 years, with a median of $647000.0 in 2024.
  • Biggest five-year swings in Liabilities and Shareholders Equity: plummeted 94.25% in 2023 and later surged 647.92% in 2024.
  • Year by year, Liabilities and Shareholders Equity stood at $2.7 million in 2021, then tumbled by 37.93% to $1.7 million in 2022, then tumbled by 94.25% to $96000.0 in 2023, then soared by 647.92% to $718000.0 in 2024, then plummeted by 92.34% to $55000.0 in 2025.
  • Business Quant data shows Liabilities and Shareholders Equity for CVAT at $55000.0 in Q4 2025, $60000.0 in Q3 2025, and $297000.0 in Q2 2025.